INTREPID will serve to empower Community citizens in the management of their individual health, to provide health care professionals and facilities with a reliable phobias treatment and decision support tool and to create new opportunities for the medical wearable device industry. INTREPID will build upon the well documented increasing demand for "healthy lifestyle" products and services on the consumer side and offer potentially significant returns for those who chose to invest in the project outcome.
The INTREPID project scientific objectives are:
The INTREPID project technological objectives are:
For further information, please visit:
http://www.intrepid-project.org
Project co-ordinator:
Manchester University (UK)
Partners:
Timetable: from 01/04 to 12/06
Total cost: 3,228,334
EC funding: 2,000,000
Instrument: STREP
Project Identifier: IST-2002-507464
Microsoft in Healthcare and Life Sciences
Company Profiles:
Agfa HealthCare |
Carestream Health |
Cetrea |
CompuGroup Medical |
CSC |
CSW Group Ltd |
dbMotion |
Dell Healthcare and Life Sciences |
EMIS |
empirica |
First DataBank |
GE Healthcare |
IBM Healthcare |
Initiate Systems |
InterComponentWare AG (ICW) |
Intel in Healthcare |
InterSystems Corporation |
iPLATO Healthcare |
iSOFT |
Map of Medicine |
Oracle Healthcare Solutions |
Orion Health |
Philips Healthcare |
Picis |
SAP for Healthcare |
Siemens Healthcare |
System C Healthcare |
Telehealth Solutions |
Tieto |
Transinsight |
Toumaz |
Tunstall | ...